Trial intelligence / Profile preview

VA HDL Intervention Trial (HIT)

NCT00283335Phase 3Completed

Sponsor
VA Office of Research & Development
Start
Jun 1991
Primary completion
Sep 1998
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of gemfibrozil in coronary heart disease (CHD), sponsored by VA Office of Research & Development. Started Jun 1991; status: completed.

02

Drugs

gemfibrozil
03

Conditions

coronary heart disease (CHD)

Beyond the preview

Go deeper on NCT00283335.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00283335.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call